Hepatic decompensation is the major driver of mortality in patients with HCC treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatmentCiro Celsa, Johann von Felden, Marco Enea et al.|Hepatology|2024Cited by 52
Liver Resection vs Nonsurgical Treatments for Patients With Early Multinodular Hepatocellular CarcinomaAlessandro Vitale, Andrea Olivani, Pierluigi Romano et al.|JAMA Surgery|2024Cited by 39